Subscribe to receive our Floor Reports covering all the action on the Texas House and Senate floor!
Summary: SB 227 would allow licensed physicians and licensed therapeutic optometrists to dispense certain aesthetic pharmaceuticals. Texas currently prohibits dispensing of certain aesthetic medications directly to patients by licensed physicians and therapeutic optometrists. SB 227 would allow physicians and therapeutic optometrists to dispense aesthetic pharmaceuticals in excess of a patient’s immediate need, for a fee, without obtaining a license to practice pharmacy under Chapter 558, Occupations code. These aesthetic pharmaceuticals include bimatoprost, hydroquinone, tretinoin, and drugs that are not controlled substances, listed with the Food and Drug Administration, require prescriptions, and are prescribed for the enhancement of an individual’s appearance.
Analysis: SB 227 increases the individual liberty of certain physicians and optometrists to prescribe aesthetic pharmaceuticals. SB 227 also promotes free markets by reducing regulation that has kept medical providers from prescribing medication they consider appropriate for their patients. We support SB 227.